381378910	381378910	CD	B-NP	O
|	|	NN	I-NP	O
ACMC	ACMC	NN	I-NP	O
|	|	NN	I-NP	O
56221906	56221906	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0403549	0403549	CD	B-NP	O
|	|	CC	I-NP	O
8/3/2005	8/3/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/13/2005	7/13/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/2005	10/24/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WHITEY	WHITEY	NNP	B-NP	O
,	,	,	O	O
OSWALDO	OSWALDO	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Et	Et	NNP	B-NP	O
Sa	Sa	NNP	I-NP	O
Rill	Rill	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
CONSIDERED	CONSIDERED	NNP	I-NP	O
:	:	:	O	O
Type	Type	NN	B-NP	O
2	2	CD	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
with	with	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
sacral	sacral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Slauson	Slauson	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
with	with	IN	B-PP	O
redo	redo	NN	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mitral	mitral	JJ	B-NP	O
and	and	CC	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
reconstruction	reconstruction	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
called	call	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
lab	lab	NN	I-NP	O
result	result	NN	I-NP	O
showed	show	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
244/4	244/4	CD	B-NP	O
.1	.1	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
all	all	DT	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	RB	I-ADVP	O
well	well	RB	I-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
for	for	IN	B-PP	O
sacral	sacral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
further	further	JJ	B-NP	O
questioning	questioning	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Satoe	Satoe	NNP	I-NP	O
reported	report	VBD	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chronic	chronic	JJ	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C-diff	C-diff	NN	B-NP	O
positivity	positivity	NN	I-NP	O
but	but	CC	O	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	O
testing	testing	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
denied	deny	VBD	B-VP	I-protein
any	any	DT	B-NP	I-protein
chest	ch	JJS	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
pleurisy	pleurisy	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
he	he	PRP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
hematuria	hematuria	NN	B-NP	O
or	or	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
hesitancy	hesitancy	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
directed	direct	VBN	I-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
his	his	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
included	include	VBD	B-VP	O
torsemide	torsemide	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
nephrotoxic	nephrotoxic	JJ	I-NP	O
agents	agent	NNS	I-NP	O
including	include	VBG	B-PP	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lisinopril	lisinopril	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
include	include	VBP	B-VP	O
heparin	heparin	NN	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
heparin-induced	heparin-induced	JJ	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
medication	medication	NN	B-NP	O
reactions	reaction	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
,	,	,	O	O
clarithromycin	clarithromycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NNP	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
reaction	reaction	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Blackmer	Blackmer	NNP	I-NP	O
is	be	VBZ	B-VP	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
x3	x3	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BP	BP	NN	I-NP	O
of	of	IN	B-PP	O
90/60	90/60	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
84	84	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
bilaterally	bilaterally	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
exam	exam	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Faint	Faint	NN	B-NP	O
S3	S3	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1/6	1/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
best	best	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
JVD	JVD	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
cm	cm	NN	I-NP	O
plus	plus	CC	O	O
V	V	NN	B-NP	O
waves	wave	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
show	show	VBP	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
petechial	petechial	JJ	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
heme	heme	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
with	with	IN	B-PP	O
tarry	tarry	NN	B-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
stage	stage	NN	I-NP	O
4	4	CD	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
well	well	RB	B-VP	O
granulated	granulate	VBN	I-VP	O
without	without	IN	B-PP	O
clear	clear	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
3.6	3.6	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
239	239	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.8	5.8	CD	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
29.3	29.3	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
4.1	4.1	CD	I-NP	I-protein
.	.	.	O	O

Admission	Admission	NN	B-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
Q	Q	NN	I-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
aVF	aVF	NN	B-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
V4	V4	NN	B-NP	O
to	to	TO	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

Left	Left	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
unchanged	unchanged	JJ	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
11/19/2005	11/19/2005	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
PA	PA	NN	B-NP	O
line	line	NN	I-NP	O
removal	removal	NN	I-NP	O
on	on	IN	B-PP	O
6/1/2005	6/1/2005	CD	B-NP	O
.	.	.	O	O

9/10/2005	9/10/2005	CD	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

6/12/2005	6/12/2005	CD	B-NP	O
,	,	,	O	O
echocardiogram	echocardiogram	NN	B-NP	O
.	.	.	O	O

6/12/2005	6/12/2005	CD	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

HOSPPITAL	HOSPPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Kristin	Kristin	NNP	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
66/2	66/2	CD	I-NP	O
.4	.4	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
rise	rise	NN	I-NP	O
between	between	IN	B-PP	O
presentation	presentation	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
noted	note	VBN	I-NP	O
value	value	NN	I-NP	O
on	on	IN	B-PP	O
11/15/2005	11/15/2005	CD	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Kayexalate	Kayexalate	NN	B-NP	O
and	and	CC	I-NP	O
sodium	sodium	NN	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
normalization	normalization	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
superelevation	superelevation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
possible	possible	JJ	B-ADJP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
Hemoccult	Hemoccult	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
as	as	IN	B-PP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
nitrogen	nitrogen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
initial	initial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
plus	plus	CC	O	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
fluid	fluid	JJ	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
reverse	reverse	VB	I-VP	O
any	any	DT	B-NP	O
potential	potential	JJ	I-NP	O
prerenal	prerenal	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Essentially	Essentially	RB	B-ADVP	O
,	,	,	O	O
all	all	DT	B-NP	O
urine	urine	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
studies	study	NNS	I-NP	O
including	include	VBG	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
and	and	CC	O	O
renal	renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showing	show	VBG	B-VP	O
normal	normal	JJ	B-NP	O
kidneys	kidney	NNS	I-NP	O
without	without	IN	B-PP	O
hydronephrosis	hydronephrosis	NN	B-NP	O
but	but	CC	B-PP	O
without	without	IN	B-PP	O
increased	increase	VBN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
feet	foot	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
/	/	SYM	B-NP	O
81	81	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
over	over	IN	B-PP	O
days	day	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
initial	initial	JJ	I-NP	O
renal	renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
restrictions	restriction	NNS	I-NP	O
imposed	impose	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
persistently	persistently	RB	B-NP	O
stable	stable	JJ	I-NP	O
values	value	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
9/12	9/12	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
inferior	inferior	JJ	B-NP	O
septal	septal	JJ	I-NP	O
severe	severe	JJ	I-NP	O
hypo	hypo	NN	I-NP	O
to	to	TO	B-PP	O
akinesis	akinesis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
posterior	posterior	JJ	B-NP	O
wall	wall	NN	I-NP	O
severe	severe	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
trace	trace	NN	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
valve	valve	VBP	B-VP	O
regurgitation	regurgitation	NN	B-NP	O
but	but	CC	O	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
thickness	thickness	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
normal	normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
assess	assess	VB	I-VP	O
his	his	PRP$	B-NP	B-DNA
filling	fill	VBG	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
attempt	attempt	NN	B-NP	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Marthaler	Marthaler	NNP	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
PA	PA	NN	B-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
on	on	IN	B-PP	O
11/19/2005	11/19/2005	CD	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
elevating	elevate	VBG	I-VP	O
filling	filling	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
including	include	VBG	B-PP	O
right	right	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
at	at	IN	B-PP	O
26	26	CD	B-NP	O
to	to	TO	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
65/13	65/13	CD	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
64/32	64/32	CD	I-NP	O
,	,	,	O	O
wedge	wedge	NN	B-NP	O
36	36	CD	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
sat	sit	VBD	B-VP	O
39	39	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
SVR	SVR	NN	B-NP	O
1568	1568	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
221	221	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
and	and	CC	I-NP	O
index	index	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	DT	O	O
reduced	reduce	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
PA	PA	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
tailor	tailor	NN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
nesiritide	nesiritide	NN	B-NP	O
drip	drip	NN	I-NP	O
at	at	IN	B-PP	O
0.005	0.005	CD	B-NP	O
as	as	RB	I-NP	O
well	well	RB	I-NP	O
as	as	IN	I-NP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
and	and	CC	I-NP	O
index	index	NN	I-NP	O
and	and	CC	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/6/2005	10/6/2005	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
nesiritide	nesiritide	NN	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
Lasix	Lasix	NNP	B-NP	O
continued	continue	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
short-acting	short-acting	JJ	B-NP	O
nitrates	nitrate	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
to	to	TO	B-VP	O
torsemide	torsemide	VB	I-VP	O
reaching	reach	VBG	I-VP	O
optimal	optimal	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
on	on	IN	B-PP	O
2/10/2005	2/10/2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
further	further	RB	B-VP	O
tailoring	tailor	VBG	I-VP	O
with	with	IN	B-PP	O
Imdur	Imdur	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
afterload	afterload	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
were	be	VBD	B-VP	O
preformed	preforme	VBN	I-VP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
previously	previously	RB	B-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
continuously	continuously	RB	I-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
12.5	12.5	CD	B-NP	O
briefly	briefly	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
once	once	RB	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
showed	show	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
without	without	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
or	or	CC	O	O
beta	beta	NN	B-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
in	in	IN	B-PP	O
place	place	NN	B-NP	O
which	which	WDT	B-NP	O
never	never	RB	B-ADVP	O
fired	fire	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
close	close	JJ	B-ADJP	O
to	to	TO	B-PP	O
euvolemia	euvolemia	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
approximate	approximate	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
67.6	67.6	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
included	include	VBD	B-VP	O
heme-positive	heme-positive	JJ	B-NP	O
tarry	tarry	NN	I-NP	O
stools	stool	NNS	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BUN	BUN	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
colonscopy	colonscopy	NN	I-NP	O
and	and	CC	I-NP	O
upper	upper	JJ	I-NP	O
EGD	EGD	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
without	without	IN	B-PP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
internal	internal	JJ	B-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
serologies	serology	NNS	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clarithromycin	clarithromycin	NN	B-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NNP	B-NP	O
b.i.d.	b.i.d.	RB	B-VP	O
given	give	VBN	I-VP	O
an	an	DT	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
overt	overt	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Splatt	Splatt	NNP	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
specialist	specialist	NN	I-NP	O
who	who	WP	B-NP	O
confirmed	confirm	VBD	B-VP	O
suspicion	suspicion	NN	B-NP	O
of	of	IN	B-PP	O
suboptimal	suboptimal	JJ	B-NP	O
caloric	caloric	JJ	I-NP	O
intake	intake	NN	I-NP	O
meeting	meet	VBG	B-VP	O
his	his	PRP$	B-NP	O
total	total	JJ	I-NP	O
caloric	caloric	JJ	I-NP	O
needs	need	NNS	I-NP	O
about	about	IN	B-PP	O
only	only	RB	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
needs	need	NNS	I-NP	O
are	be	VBP	B-VP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
despite	despite	IN	B-PP	O
labilization	labilization	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
Megace	Megace	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
nutritional	nutritional	JJ	I-NP	O
goals	goal	NNS	I-NP	O
were	be	VBD	B-VP	O
even	even	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
important	important	JJ	I-ADJP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
large	large	JJ	I-NP	O
stage	stage	NN	I-NP	O
4	4	CD	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
healing	healing	NN	I-NP	O
since	since	IN	B-PP	O
January	January	NNP	B-NP	O
2005	2005	CD	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
encouragement	encouragement	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
appetite	appetite	JJ	B-NP	O
stimulants	stimulant	NNS	I-NP	O
with	with	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
zinc	zinc	NN	B-NP	O
,	,	,	O	O
mineral	mineral	NN	B-NP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
supplements	supplement	NNS	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presently	presently	RB	B-ADVP	O
fell	fall	VBD	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
goals	goal	NNS	I-NP	O
but	but	CC	O	O
refused	refuse	VBD	B-VP	O
other	other	JJ	B-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
diet	diet	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
including	include	VBG	B-PP	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
placement	placement	NN	I-NP	O
and	and	CC	O	O
PEG	PEG	NN	B-NP	O
placement	placement	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
provide	provide	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
met	meet	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
registered	register	VBN	I-NP	O
dietitian	dietitian	JJ	I-NP	O
and	and	CC	O	O
understand	understand	VBP	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
caloric	caloric	JJ	I-NP	O
intakes	intake	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
view	view	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
stage	stage	NN	B-NP	O
4	4	CD	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
plastic	plastic	NN	B-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
frequently	frequently	RB	B-VP	O
debrided	debride	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bastress	Bastress	NNP	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
team	team	NN	I-NP	O
,	,	,	O	O
followed	follow	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
protocol	protocol	NN	B-NP	O
with	with	IN	B-PP	O
b.i.d.	b.i.d.	JJ	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
Panafil	Panafil	NN	B-NP	O
and	and	CC	O	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
for	for	IN	B-PP	O
suspicion	suspicion	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
given	give	VBN	I-NP	O
MRSA	MRSA	NN	I-NP	O
growth	growth	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
Klebsiella	Klebsiella	NNP	I-NP	O
growth	growth	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
discontinued	discontinue	VBN	B-VP	O
on	on	IN	B-PP	O
10/6/2005	10/6/2005	CD	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
plastic	plastic	NN	B-NP	O
recommendations	recommendation	NNS	I-NP	O
given	give	VBP	B-VP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
probability	probability	NN	I-NP	O
colonization	colonization	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
would	would	MD	B-VP	O
provide	provide	VB	I-VP	O
appropriate	appropriate	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
right	right	NN	I-NP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
questioned	question	VBN	B-VP	O
on	on	IN	B-PP	O
x-ray	x-ray	NN	B-NP	B-DNA
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
endocrinology	endocrinology	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Lantus	Lantus	NNP	I-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NNP	I-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
with	with	IN	B-PP	O
titration	titration	NN	B-NP	O
of	of	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
wound	wound	NN	B-NP	O
healing	healing	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
rheumatologic	rheumatologic	JJ	B-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
colchicine	colchicine	NN	B-NP	O
helps	help	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
about	about	IN	B-NP	O
1/6/2005	1/6/2005	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
podagra	podagra	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
quick	quick	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
hematologic	hematologic	JJ	B-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
anemia	anemia	NN	B-NP	O
baseline	baseline	NN	I-NP	O
and	and	CC	O	O
takes	take	VBZ	B-VP	O
Procrit	Procrit	NNP	B-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
on	on	IN	B-PP	O
8/18	8/18	CD	B-NP	O
and	and	CC	O	O
maintained	maintain	VBD	B-VP	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
darbepoetin	darbepoetin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
.	.	.	O	O

Laboratory	Laboratory	NN	B-NP	O
data	datum	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hemolysis	hemolysis	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
haptoglobin	haptoglobin	NN	I-NP	O
and	and	CC	I-NP	O
LDH	LDH	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
iron	iron	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
supratherapeutic	supratherapeutic	JJ	I-NP	O
levels	level	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
optimize	optimize	VBP	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
know	know	VB	B-VP	O
to	to	TO	I-VP	O
correspond	correspond	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
small	small	JJ	I-NP	O
right	right	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
with	with	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
exam	exam	NN	I-NP	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S3	S3	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1/6	1/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVD	JVD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
11	11	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
lab	lab	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
3.6	3.6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
32.1	32.1	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
9000	9000	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
0.8	0.8	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
3	3	CD	B-NP	O
.	.	.	O	O

CONSULTATNTS	CONSULTATNTS	NNS	B-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Bingaman	Bingaman	NNP	I-NP	O
from	from	IN	B-PP	O
Ox	Ox	NNP	B-NP	O
Derd	Derd	NNP	I-NP	O
Peake	Peake	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Crisan	Crisan	NNP	I-NP	O
from	from	IN	B-PP	O
GI	GI	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Whidbee	Whidbee	NNP	I-NP	O
from	from	IN	B-PP	O
plastic	plastic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
Armando	Armando	NNP	B-NP	O
Mishulovin	Mishulovin	NNP	I-NP	O
from	from	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
management	management	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

DISCARGE	DISCARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhale	inhale	JJ	B-ADJP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
relieving	relieving	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.0625	0.0625	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Megace	Megace	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
administered	administer	VBN	I-VP	O
sequentially	sequentially	RB	B-ADVP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
1	1	CD	I-NP	O
table	table	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
zinc	zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
40	40	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
14	14	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
potasium	potasium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
tablets	tablet	NNS	I-NP	O
40	40	CD	B-NP	O
mEq	mEq	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Procrit	Procrit	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
pending	pende	VBG	I-NP	O
tests	test	NNS	I-NP	O
or	or	CC	O	O
followup	followup	NN	B-NP	O
tests	test	NNS	I-NP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Leandro	Leandro	NNP	I-NP	O
Deprez	Deprez	NNP	I-NP	O
He	He	NNP	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHSYICAIAN/HEALTH	PHSYICAIAN/HEALTH	NN	I-NP	O
OFFICICER	OFFICICER	NN	I-NP	O
:	:	:	O	O
Odis	Odis	NNP	B-NP	O
Mike	Mike	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-2978751	1-2978751	CD	B-NP	O
RW	RW	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
NOBLITT	NOBLITT	NNP	B-NP	O
,	,	,	O	O
ZACHERY	ZACHERY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DELRIO	DELRIO	NNP	B-NP	O
,	,	,	O	O
MACK	MACK	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4107833	4107833	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/21/05	10/21/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/18/05	2/18/05	CD	B-NP	O

